Is CBD legal in Australia?

Legal status

Prescription only medicine, with a pharmacist only tier, and a border controlled drug. F2026L01327 places cannabidiol in Schedule 4: «CANNABIDIOL in preparations for therapeutic use or analytical and scientific research where: (a) cannabidiol comprises 98% or more of the total cannabinoid content of the preparation; and (b) any cannabinoids, other than cannabidiol, must be only those naturally found in cannabis and comprise 2% or less of the total cannabinoid content of the preparation; except when: (c) included in Schedule 3; or (d) in hemp seed oil at a concentration of 75 mg/kg or less.» Schedule 3 covers registered oral, oromucosal and sublingual products with «the maximum recommended daily dose is 150 mg or less of cannabidiol», «packs containing not more than 30 days’ supply» and supply «for persons aged 18 years and over». A preparation outside the 98% purity condition is cannabis or a cannabis extract in Schedule 9, or Schedule 8 when it meets the medicinal cannabis entry. Schedule 2 item 35 of the Criminal Code Regulations 2019 lists «Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant)» as a border controlled drug (commercial 2.0 kg, marketable 2.0 g). Cannabidiol is a cannabinoid of the cannabis plant, so importing it is a Division 307 matter unless done under a licence and permission or the traveller exemption. For the controlled drug offences CBD needs s301.9, and it falls outside it. Apart from item 35, it is not listed in Schedule 1 or Schedule 2 of the Criminal Code Regulations 2019 (Compilation No. 6). Nearest listed drug: tetrahydrocannabinols, THC (Schedule 1 item 238). Limb (a) of s301.9(1) does not reach it because although CBD and THC share the formula C21H30O2, s301.9(1)(a)(ii) needs «a structural isomer having the same constituent groups», and CBD carries two hydroxy groups where THC carries one hydroxy group and a ring ether; limb (c) does not, because CBD is THC with its central pyran ring opened, and removing a ring is none of the s301.9(1)(c) modifications; and on the method stated next limb (d) does not, because opening a ring puts it outside s301.9 on that method. The method used for every row is a reading, not a rule the Act states: a modification that limb (a) or limb (c) plainly describes is treated as making a drug analogue; one contestable modification (a swap within one paragraph of s301.9(2), or a core ring replaced), a single limb (d) change from the listed drug, or an express exclusion or different listing in the Regulations is treated as making the exposure conditional; anything more, including adding or removing a ring, is treated as outside s301.9. Because s301.9(1)(c) allows a modification «obtained in one or more of the following ways», the tier this gives can depend on how a change is described, and nothing read settles which description governs. No court decision applying s301.9 to cannabidiol was read, so this is a reading of the text. Customs (Prohibited Imports) Regulations 1956 Schedule 4 item 34 («34 Cannabinoids»). The Poisons Standard read is the Poisons Standard October 2026 (Federal Register of Legislation F2026L01327, made 28 September 2026, registered 30 September 2026, in force from 1 October 2026 under its s2, replacing the June 2026 issue; no later issue was registered when it was read). This cell states Commonwealth law only. The Poisons Standard has effect through adoption by each state and territory: its Reader's guide, which s5(1) of the instrument says is not part of it, states «The scheduling of poisons is implemented through relevant State and Territory legislation.» Most personal possession and use offences are state and territory law, which differs by jurisdiction, and Criminal Code s300.4 keeps those laws running concurrently with Part 9.1. Read as in force on 2 October 2026 against F2026L01327, the Criminal Code Act 1995 at Compilation No. 174 (compilation date 30 June 2026, C2026C00243), the Criminal Code Regulations 2019 at Compilation No. 6 (compilation date 13 December 2025, F2025C01260) and the Customs (Prohibited Imports) Regulations 1956 at Compilation No. 147 (compilation date 13 July 2026, F2026C00751). The Criminal Code Regulations schedules are made by the Governor-General and the Poisons Standard by a delegate of the Secretary under Therapeutic Goods Act 1989 s52D, so a later instrument can change any of this, and this reading does not rule out a later amendment.

Consequences if caught

Capital exposure: none. The highest penalty anywhere in Part 9.1 of the Criminal Code is imprisonment for life, and Death Penalty Abolition Act 1973 s6 provides «The punishment of death must not be imposed as the penalty for any offence referred to in subsection 3(2) or (3).» The Division 307 import and export offences are the only Commonwealth criminal offences reaching CBD. Import and export are offences of their own in Division 307 against the border controlled drug listing (Schedule 2 item 35): s307.3, imprisonment for 10 years or 2,000 penalty units, or both, with a defence if the person proves no intention or belief that any would be sold; s307.4, which needs no commercial intent, 2 years or 400 penalty units, or both; s307.2 for a marketable quantity (2.0 g or more), 25 years or 5,000 penalty units, or both; s307.1 for a commercial quantity (2.0 kg or more), imprisonment for life or 7,500 penalty units, or both. Possessing an unlawfully imported quantity is s307.5 to s307.7 on the same thresholds, and possessing one reasonably suspected of unlawful import is s307.8 to s307.10. The Customs Act s233(5) leaves border controlled drugs to these offences rather than to the Customs Act smuggling offence. Possession, sale and supply within Australia are not Commonwealth offences for CBD; they are state and territory poisons offences built on its Schedule 3, 4, 8 or 9 placement. There is no Commonwealth offence of using or consuming a drug; use is left to state and territory law. A penalty unit is $364 for an offence committed on or after 1 July 2026 under the Crimes (Amount of a Penalty Unit) Instrument 2026 (F2026N00424), made under Crimes Act 1914 s4AA, so 400 penalty units is $145,600, 2,000 is $728,000 and 7,500 is $2,730,000; «or both» in each penalty means the prison term and the fine are available alternatively or together.

If prescribed or medical

Schedule 4 makes a CBD preparation a prescription only medicine. The Reader's guide, which is not part of the instrument, describes Schedule 4 as «Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.» A registered Schedule 3 product may be sold by a pharmacist without prescription to an adult within the 150 mg daily dose and 30 day pack limits quoted above. Products not entered in the Australian Register of Therapeutic Goods are prescribed through Therapeutic Goods Act approval pathways. The Narcotic Drugs Act 1967 (Compilation No. 16, compilation date 14 October 2024) also applies, because it defines drug as «any substance that is a drug for the purposes of the Convention», the Single Convention on Narcotic Drugs, 1961: it licenses the manufacture of narcotic drugs through manufacture licences and permits.

Documentation

Traveller rule, Commonwealth: regulation 5(2)(b) of the Customs (Prohibited Imports) Regulations 1956 lifts the import prohibition for a drug carried by a passenger on a ship or aircraft that «is required for the medical treatment of the person or of another passenger under the care of the person», «was prescribed by a medical practitioner for the purposes of that treatment» and «was supplied to the person in accordance with the prescription of the medical practitioner referred to in subparagraph (ii)». Therapeutic Goods Regulations 1990 Schedule 5 item 1 (Compilation No. 130, compilation date 8 September 2026) covers «therapeutic goods that are imported for therapeutic use in the treatment of the importer or the importer’s immediate family» and limits the personal import to «not more than 3 months’ supply at the maximum dose recommended by the manufacturer» in one importation and, for goods in Schedule 4 or Schedule 8 of the current Poisons Standard, requires a written authority from a medical practitioner, or an overseas medical practitioner where the goods are carried by a passenger. The Australian Border Force traveller guidance (abf.gov.au, read 2 October 2026) asks the traveller to «carry a letter or copy of your prescription (written in English) from your doctor to certify that the medicine has been prescribed to you to treat a medical condition», to keep the medicine in its original packaging and to declare it on arrival. Anything outside that exemption needs an import licence and permission from the Office of Drug Control under regulation 5(1). Where the medicine is also a border controlled drug, Division 307 of the Criminal Code has no traveller exception of its own; the traveller relies on Criminal Code s10.5, «A person is not criminally responsible for an offence if the conduct constituting the offence is justified or excused by or under a law.», on the footing that an import within regulation 5(2)(b) is so excused. That footing is this cell's reading of the provisions; no decision applying it was read. The Therapeutic Goods Administration and Office of Drug Control traveller pages (tga.gov.au, odc.gov.au) did not respond from this network on 2 October 2026 (curl timeout after 60 seconds, twice, and a second fetcher timed out), so nothing in this cell rests on them.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Australia’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.